HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cynthia J Davis Selected Research

Chemoradiotherapy

12/2012Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cynthia J Davis Research Topics

Disease

1Neurofibromatosis 1 (Neurofibromatosis Type I)
12/2012
1Neutropenia
12/2012
1Plexiform Neurofibroma
12/2012

Drug/Important Bio-Agent (IBA)

1Imatinib Mesylate (Gleevec)FDA Link
12/2012
1Transaminases (Aminotransferases)IBA
12/2012

Therapy/Procedure

1Chemoradiotherapy
12/2012